Skip to main content

Exercise in Specific Diseases: Coronary Artery Disease

  • Chapter
  • First Online:
Textbook of Sports and Exercise Cardiology

Abstract

Coronary artery disease (CAD) is a progressive disease, typically starting early in life. CAD is strongly associated with cardiovascular morbidity and mortality. Regular physical activity (PA) has positive effects on multiple risk factors for CAD, while high-intensity PA may act as a trigger for sudden cardiac death, especially in susceptible individuals with an underlying cardiovascular abnormality. Therefore, recommendations for cardiovascular evaluation of older individuals aiming to participate in leisure-time or competitive sports, as well as for those with risk factors for or with established CAD, has been established. If athletes with an increased risk profile for CAD show a normal, truly maximal exercise test, they are not restricted from any competitive sport. Patient-athletes with clinically proven CAD and considered to be at low-risk for cardiac events may be selectively advised to participate in competitive sports but restrictions may apply on an individual basis for certain sports with the highest CV demand (such as extreme power and endurance disciplines) and in older athletes, having a higher risk. Patient-athletes with clinically proven CAD, defined as high risk, should receive appropriate management and be restricted from competitive sport. In patient-athletes with CAD and significant ischemia during exercise, as in all patients, anti-ischemic therapy needs to be optimized. In case of inducible ischemia, revascularization is strongly suggested. Athletes considered as “low-risk” for cardiac events post-MI and/or post-PCI are recommended a minimum of 3 months structured and progressive rehabilitation before assuming/resuming participation in competitive sports. Periodical, at least annual follow-ups of athletes with CAD are recommended, including risk factor management by lifestyle and medications, according to guidelines. Any symptoms should be evaluated, and repeated exercise-testing could be used, for risk stratification and/or modified exercise prescription.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Palmefors H, DuttaRoy S, Rundqvist B, Borjesson M. The effect of physical activity or exercise on key biomarkers in atherosclerosis–a systematic review. Atherosclerosis. 2014;235(1):150–61.

    Article  CAS  Google Scholar 

  2. Strong JP, Malcolm GT, McMahan CA, Tracy RE, Newman WP, Herderick EE, et al. Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the pathobiological determinants of atherosclerosis in youth study. JAMA. 1999;281:727–35.

    Article  CAS  Google Scholar 

  3. Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, et al. 2013 ESC guidelines on the management of stable coronary artery disease. Eur Heart J. 2013;34:2949–3003.

    Article  Google Scholar 

  4. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2015;385:117–71.

    Article  Google Scholar 

  5. Anand SS, Islan S, Rosengren A, Franzosi MG, Steyn K, Yusufali AH, et al. Risk factors for myocardial infarction in women and men: insights from the INTERHEART study. Eur Heart J. 2008;29:932–40.

    Article  Google Scholar 

  6. Blair SN, Morris JN. Healthy hearts and the beneficial effect of being physically active. Ann Epidemiol. 2009;19:253–6.

    Article  Google Scholar 

  7. Piepoli M, Hoes A, Agewall S, Albus C, Brotons C, Catapano A, et al. 2016 European guidelines on cardiovascular disease prevention in clinical practice: The sixth joint task force of the European Society of Cardiology and other socities on cardiovascular disease prevention in clinical practice. Eur Heart J. 2016;37:2315–81.

    Article  Google Scholar 

  8. Ng SW, Popkin BM. Time use and physical activity: a shift away from movement across the globe. Obes Rev. 2012;13(8):659–80.

    Article  CAS  Google Scholar 

  9. Ekblom-Bak E, Ekblom O, Andersson G, Wallin P, Soderling J, Hemmingsson E, et al. Decline in cardiorespiratory fitness in the Swedish working force between 1995 and 2017. Scand J Med Sci Sports. 2018;29(2):232–9.

    Article  Google Scholar 

  10. Albert CM, Mittleman MA, Chae CU, Lee IM, Hennekens CH, Manson JE. Triggering of sudden death from cardiac causes by vigorous exertion. N Engl J Med. 2000;343:1355–61.

    Article  CAS  Google Scholar 

  11. Mittleman MA, Maclure M, Tofler GH, Sherwood JB, Goldberg RJ, Muller JE. Triggering of acute myocardial infarction by heavy physical exertion. Protection against triggering by regular exercise. N Engl J Med. 1993;329:1677–83.

    Article  CAS  Google Scholar 

  12. Williams PT, Thompson PD. Increased cardiovascular disease mortality associated with excessive exercise in heart attack survivors. Mayo Clin Proc. 2014;89:1187–94.

    Article  Google Scholar 

  13. Gerardin B, Collet JP, Mustafic H, Bellemain-Appaix A, Benamer H, Monsegu J, et al. Registry on acute cardiovascular events during endurance running races: the prospective RACE Paris registry. Eur Heart J. 2016;37:2531–41.

    Article  Google Scholar 

  14. Meyer L, B S, C F, C M, K H, M E, et al. Incidence, cases and survival trends from cardiovascular-related sudden cardiac arrest in children and young adults 0 to 35 years of age: a 30-year review. Circulation. 2012;126:1363–72.

    Article  Google Scholar 

  15. Kim JH, Malhotra R, Chiampas G, d´Hemecourt P, Troyanos C, Cianca J, et al. Cardiac arrest during long-distance running races. Race associated cardiac arrest event registry (RACER) study group. N Engl J Med. 2012;366:130–40.

    Article  CAS  Google Scholar 

  16. Frisk-Torell M, Stromsoe A, Zagerholm E, Herlitz J, Claesson A, Svensson L, et al. Higher survival rates in exercise-related out-of-hospital cardiac arrests, compared to non-exercise related- a study from the Swedish register of cardiopulmonary resuscitation. Eur J Prev Cardiol. 2017;24:1673–9.

    Article  Google Scholar 

  17. Thompson PD, Franklin BA, Balady GJ, Blair SN, Corrado D, EstesIII NAM, et al. Exercise and acute cardiovascular events. Placing the risks into perspective. A scientific statement from the American Heart Association council on nutrition, physical activity, and metabolism and the council on clinical cardiology. Circulation. 2007;115:2358–68.

    Article  Google Scholar 

  18. Quillard T, Franck G, Mawson T, Folco E, Libby P. Mechanisms of erosion of atherosclerotic plaques. Curr Opin Lipidol. 2017;28:434–41.

    Article  CAS  Google Scholar 

  19. Börjesson M, Urhausen A, Kouidi E, Dugmore D, Sharma S, Halle M, et al. Cardiovascular evaluation of middle-aged/senior individuals engaged in leisure-time sport activities: position stand from the section of exercise physiology and sports cardiology of the European Association of Cardiovascular Prevention and Rehabilitation. Eur J Cardiovasc Prev Rehabil. 2011;18:446–58.

    Article  Google Scholar 

  20. Borjesson M, Dellborg M, Niebauer J, LaGerche A, Schmied C, Solberg EE, et al. Recommendations for participation in leisure-time or competitive sports in athletes-patients with coronary artery disease-A position statement from the sports cardiology section of the European association of preventive cardiology (EAPC). Eur Heart J. 2019;40:13–8.

    Article  Google Scholar 

  21. Aagaard P, Sahlén A, Braunschweig F. Performance trends and cardiac biomarkers in a 30-km cross-country race, 1993–2007. Med Sci Sports Exerc. 2012;44:894–9.

    Article  Google Scholar 

  22. Greenland P, LaBree L, Axzen SP, Doherty TM, Detrano RC. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA. 2004;291:563.

    Article  CAS  Google Scholar 

  23. Saad M, Pothineni NV, Thomas J, Parikh R, Kovelamundi S, Elsayed D, et al. Coronary artery calcium scoring in young adults: evidence and challenges. Curr Cardiol Rep. 2018;20:10.

    Article  Google Scholar 

  24. Mohlenkamp S, Lehmann N, Breuckmann F, Brocker-Preuss M, Nassenstein K, Halle M, et al. Running: the risk of coronary events : prevalence and prognostic relevance of coronary atherosclerosis in marathon runners. Eur Heart J. 2008;29(15):1903–10.

    Article  Google Scholar 

  25. Aengevaeren VL, Mosterd A, Braber TL, Prakken NHJ, Doevendans PA, Grobbee DE, et al. Relationship between lifelong exercise volume and coronary atherosclerosis in athletes. Circulation. 2017;136:138–48.

    Article  CAS  Google Scholar 

  26. Balady GJ, Chaitman B, Driscoll D, Foster C, Froelicher E, Gordon N, et al. Recommendations for cardiovascular screening, staffing, and emergency policies at health/fitness facilities. Circulation. 1998;97:2283–93.

    Article  CAS  Google Scholar 

  27. Pelliccia A, Adami PE, Quattrini F, Squeo MR, Caselli S, Verdile L, et al. Are Olympic athletes free from cardiovascular diseases? Systematic investigation in 2352 participants from Athens 2004 to Sotchi 2014. Br J Sports Med. 2017;51(4):238–43.

    Article  Google Scholar 

  28. Anderson L, Thompson DR, Oldridge N, Zwisler AD, Rees K, Martin N, et al. Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database Syst Rev. 2016;1(Jan 5):CD001800.

    Google Scholar 

  29. Mitchell BL, Lock MJ, Davison K, Parfitt G, Buckley JP, Eston RG. What is the effect of aerobic exercise intensity on cardiorespiratory fitness in those undergoing cardiac rehabilitation? A systematic review with meta-analysis. Br J Sports Med. 2018;53(21):1341–51. epub ahead of print

    Google Scholar 

  30. Ek A, Ekblom O, Hambraeus K, Cider A, Kallings LV, Borjesson M. Physical inactivity and smoking after myocardial infarction as predictors for readmission and survival- Results from the SWEDEHEART-registry. Clin Res Cardiol. 2018;108(3):324–32.

    Article  Google Scholar 

  31. Ekblom O, Ek A, Cider A, Hambraeus K, Borjesson M. Increased physical activity post-myocardial infarction is related to reduced mortality-results from the Swedeheart registry. J Am Heart Assoc. 2018;7:e010108.

    Article  CAS  Google Scholar 

  32. Mons U, Hahmann H, Brenner H. A reverese J-shaped association of leisure-time physical activity prognosis in patients with stable coronary heart disease: evidence from a large cohort with repeated measurements. Heart. 2014;100:1043–9.

    Article  Google Scholar 

  33. Onerup A, Arvidsson D, Blomqvist A, Daxberg E-L, Jivegard L, Jonsdottir IH, et al. Physical activity on prescription in accordance with the Swedish model increases physical activity: a systematic review. Br J Sports Med. 2018;53(6):383–8.

    Article  Google Scholar 

  34. Pelliccia A, Fagard R, Bjornstad HH, Anastassakis A, Arbustini E, Assanelli D, et al. Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the study group of sports cardiology of the working group of cardiac rehabilitation and exercise physiology and the working group of myocardial and pericardial diseases of the European society of cardiology. Eur Heart J. 2005;26(14):1422–45.

    Article  Google Scholar 

  35. Thompson P, Myerburg R, Levine B, Udelson J, Kovacs R. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 8: coronary artery disease. A scientific statement from the American Heart Association and the American College of Cardiology. Circulation. 2015;132:e310–4.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mats Börjesson .

Editor information

Editors and Affiliations

Case Presentations

Case Presentations

1.1 Case 1

Glenn is a 63-year old man, formerly manual worker but these days mostly office work. He seeks medical advice since he has entered into a betting contest with his son: Glenn has pledged to enter, and finish, a local 21 km half marathon race next spring. He refers to himself as interested in sports, with an active interest in sports, in particular soccer. He also played in a national low-level league in his youth. Before starting practice for the race, his wife has insisted on a medical check-up and you agree to see him.

Glenn is modestly overweight with a BMI of 29.5, waist circumference is 105 cm, sitting blood pressure is 160/90, LDL-cholesterol of 3.2 mmol/l (123 mg/dl), total cholesterol is 6.1 mmol/l (235 mg/dl), fasting glucose is at the upper limit of normal, ECG at rest shows normal sinus rhythm without ST-changes. Glenn smoked for about 10 years but stopped at 30 years of age. His wife complains that he snores a lot and for this reason they do not share the same bedroom anymore. He has no symptoms on exercise, his two older brothers are healthy, his father suffered from stroke at 72 years of age and his mother is healthy at 91. Upon questioning, it becomes evident that he has done little exercise during at least the last 10–15 years.

So what do we need to consider?

  • What is he intending to do? 21 km half marathon, which is a substantial effort

  • What is his level of fitness? We don’t really know but probably quite low.

  • What are his risk factors and his 10-year risk? According to the SCORE diagram his risk is about 10% for fatal CVD within the next 10 years, thus he is not in a low-risk category.

1.1.1 Questions

  1. 1.

    Do we need additional workup?

  2. 2.

    Do we need to do more?

  3. 3.

    What would our advice be to Glenn?

1.1.2 Answers

  1. 1.

    Yes, a truly maximal exercise test should be performed. This was done and was completely normal; he reached a maximum load of 155 W (slightly below average for age/sex/weight), maximum heart rate of 158, no chest pain, no arrhythmias, adequate evolution of blood pressure, no ST-changes.

  2. 2.

    We need to address his risk factors i.e. re-check his blood pressure, give dietary advice for cholesterol, advice on weight loss. Given the normal exercise test, no further evaluation is required.

  3. 3.

    He needs to start regular exercise, should start on a modest level since his fitness is also modest. If he can successfully train regularly there is no reason to prohibit him from entering the 21 km race, in the coming spring.

1.2 Case 2

Björn is a 46-year-old man, never smoked, regular physical activity, in particular greatly into cycling. He frequently participates in competitive bicycle races. When doing a 120 km 1-day race in the French alps, he developed chest pain during a long climb. He managed to finish the race but then sought medical attention. An ECG showed inferior ST-depression and troponin was elevated. A coronary angiogram revealed a subtotal occlusion of the proximal right coronary artery, due to a thrombus at the site of a ruptured plaque. Residual stenosis was less than 50% and no angioplasty was therefore done. He was given a statin, ACE inhibitor, dual antiplatelet treatment and discharged from hospital. He comes to see you after 4 weeks, is about to return to work full time and is anxious to go back to training.

At this visit he is in good general condition, reports no chest pain, his blood pressure is 120/70 mmHg, LDL cholesterol is 1.9 mmol/l (73 mg/dl), glucose normal, BMI 24, ECG shows sinus rhythm, 48/min, inferiorly negative T-waves.

So what do we need to consider?

  • He is a patient with stable coronary artery disease, survived an MI, and his risk factors are under control.

  • What does he intend to do? He wants to go back to competitive cycling on a high to extreme level of effort.

  • What is his level of fitness? Probably quite good although he hasn’t been training for the last month.

  • What are his risk factors? He has a 50% residual stenosis, is free from angina, has no palpitations, and his risk factors are rather well controlled.

1.2.1 Questions

  1. 1.

    Do we need additional workup?

  2. 2.

    What would your advice be to Björn?

1.2.2 Answers

  1. 1.

    We need to know how his left ventricular function is and how he performs on a maximum exercise test. One may also consider adding an isotope to the exercise test or re-do the angiogram. An echocardiogram was done at the visit, which showed slight inferior hypokinesia, overall good left ventricular function with an EF of 55%, normal valvular function. A maximum exercise test was done the following day, showing good exercise capacity with a maximum load of 250 W, maximum heart rate of 172/min, no signs of ischemia, no arrhythmias and no symptoms.

  2. 2.

    He is now free to go back to training and may go back to competitive cycling but has to understand that as a MI survivor his risk of further cardiac events including cardiac death will be increased both at rest and during exercise.

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Börjesson, M., Niebauer, J., Dellborg, M. (2020). Exercise in Specific Diseases: Coronary Artery Disease. In: Pressler, A., Niebauer, J. (eds) Textbook of Sports and Exercise Cardiology. Springer, Cham. https://doi.org/10.1007/978-3-030-35374-2_44

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-35374-2_44

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-35373-5

  • Online ISBN: 978-3-030-35374-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics